Registry of Lobbyists
Version 9 of 63 (2008-06-20 to 2008-08-13) was submitted prior to the Lobbying Act coming into force on July 2, 2008. Due to different information requirements at that time, the registration is presented in the following format.
| Corporation: |
Hoffmann-La Roche Limited
2455 Meadowpine Blvd. Mississauga, ON L5N 6L7 Canada |
| Telephone number: | 905-542-5555 |
| Fax number: | 905-542-7130 |
| Responsible officer name and position during the period of this registration: | RONNIE MILLER, PRESIDENT AND CEO |
| Description of activities: | Hoffmann-La Roche Limited deals with the healthcare system in the prevention, screening, diagnosis, treatment and management of acute and long-term disease and supports leading research and development - including clinical research, clinical trials and genetic research. |
| The client is a subsidiary of the following parent companies: |
F. Hoffmann-La Roche AG
Grenzacherstrasse 124 4070 Basle Switzerland |
| Coalition | The corporation is not a member of a coalition. |
| Subsidiary: | The corporation does not have any subsidiaries that could be affected by the outcome of the undertaking. |
| Other direct interests | The corporation's activities are not controlled or directed by another individual, organization or corporation with a direct interest in the outcome of this undertaking. |
| Was the corporation funded in whole or in part by any domestic or foreign government institution in the last completed financial year? | No |
| Name: | Michèle Beaubien |
| Position title: | Executive Director, Government and Corporate Affairs |
| Public offices held: | No |
| Name: | Lorenzo Biondi |
| Position title: | Vice President, Medical & Regulatory Affairs |
| Public offices held: | No |
| Name: | Ciro Caravaggio |
| Position title: | VP, Oncology, Hematology & Rheumatology Business Units |
| Public offices held: | No |
| Name: | Jean-Guy Cyr |
| Position title: | National Manager, Health Policy and Government Relations |
| Public offices held: | No |
| Name: | Linnea Doyle |
| Position title: | Director of Market Access |
| Public offices held: | No |
| Name: | James Hall |
| Position title: | VP, Urgent Care, Transplant, Virology & AVA Business Units |
| Public offices held: | No |
| Name: | Nabil Henein |
| Position title: | Director, Regulatory Affairs |
| Public offices held: | No |
| Name: | Jamie Slater |
| Position title: | Product Manager |
| Public offices held: | No |
| Name: | Ilona Torontali |
| Position title: | Vice President, Public Affairs |
| Public offices held: | No |
| Name: | Bridget Wells |
| Position title: | Director of Health Policy and Government Relations |
| Public offices held: | No |
| Name: | James Willoughby |
| Position title: | Vice President, General Counsel & Corporate Secretary |
| Public offices held: | No |
| Federal departments or organizations which have been or will be communicated with during the course of the undertaking: | Aboriginal Affairs and Northern Development Canada, Agriculture and Agri-Food Canada (AAFC), Atlantic Canada Opportunities Agency (ACOA), Canadian International Development Agency (CIDA), Canadian International Trade Tribunal (CITT), Canadian Space Agency (CSA), Canadian Transportation Agency (CTA), Citizenship and Immigration Canada, Competition Tribunal (CT), Correctional Service of Canada (CSC), Environment Canada, Federal Office of Regional Development – Quebec (FORD[Q]), Finance Canada (FIN), Foreign Affairs and International Trade Canada (DFAITC), Health Canada (HC), Human Resources Development Canada (HRDC), Industry Canada, Justice Canada (JC), Members of the House of Commons, National Defence (DND), National Research Council (NRC), Natural Resources Canada (NRCan), Natural Sciences and Engineering Research Council (NSERC), Office of the Auditor General, Office of the Information and Privacy Commissioner (OIPC), Patented Medicine Prices Review Board (PMPRB), Prime Minister's Office (PMO), Privy Council Office (PCO), Public Safety and Emergency Preparedness Canada (PSEPC), Public Service Commission of Canada (PSC), Public Works and Government Services Canada, Revenue Canada (RC), Royal Canadian Mounted Police (RCMP), Senate of Canada, Service Canada (ServCan), Solicitor General Canada (SGC), Statistics Canada (StatCan), Transport Canada (TC), Treasury Board Of Canada Secretariat (TBS), Veterans Affairs Canada (VAC), Western Economic Diversification Canada (WD) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Communication techniques that have been used or are expected to be used in the course of the undertaking:
|
Meetings, Presentations, Telephone calls, Written communications, whether in hard copy or electronic format | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Subject Matter: Areas of Concern: | Aboriginal Affairs, Agriculture, Constitutional Issues, Consumer Issues, Defence, Education, Employment and Training, Energy, Environment, Financial Institutions, Fisheries, Forestry, Government Procurement, Health, Immigration, Industry, Infrastructure, Intellectual Property, Internal Trade, International Relations, International Trade, Justice and Law Enforcement, Labour, Regional Development, Science and Technology, Small Business, Sports, Taxation and Finance, Transportation | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Subject Matter: Retrospective: | Treasury Board: Smart Regulations, pandemic planning. Industry Canada: Science and Technology Strategy, Patent Medicine Notice of Compliance regulations, Medical Devices regulations, Patent Act, pharmaceutical and biotechnology Research and Development issues, smart regulations, patent policy, life sciences industry, international aid programs. Health Canada: drug safety, data protection regulations, innovation issues, drug approval, pandemic planning, international aid programs, national pharmaceutical strategy, biotechnology, smart regulations, Food and Drugs Act, in vitro device medical device safety, in vitro device medical device approval, Progressive Licensing Framework, review process, Canada's Access to Medicines Regime, Subsequent Entry Biologics, Risk communications to Canada from manufacturers, health professionals and consumers, to the public via Health Canada and manufacturers, and Product Monographs, Food and Consumer Safety Action Plan, Clinical trials regulations and registrations, Post Notice of Compliance Change Guidance: Quality, Access to Information, and International Memorandum of Understandings. Foreign Affairs/Trade: ongoing international issues, patent issues, access and benefit sharing issues, international aid programs. Finance: Budget and budget update. CIDA: international aid programs. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Subject Matter: Prospective: | Treasury Board: Smart Regulations, pandemic planning. Industry Canada: Science and Technology Strategy, Patent Medicine Notice of Compliance regulations, Medical Devices regulations, Patent Act, pharmaceutical and biotechnology Research and Development issues, smart regulations, patent policy, life sciences industry, international aid programs. Health Canada: drug safety, data protection regulations, innovation issues, drug approval, pandemic planning, international aid programs, national pharmaceutical strategy, biotechnology, smart regulations, Food and Drugs Act, in vitro device medical device safety, in vitro device medical device approval, Progressive Licensing Framework, review process, Canada's Access to Medicines Regime, Subsequent Entry Biologics, Risk communications to Canada from manufacturers, health professionals and consumers, to the public via Health Canada and manufacturers, and Product Monographs, Food and Consumer Safety Action Plan, Clinical trials regulations and registrations, Post Notice of Compliance Change Guidance: Quality, Access to Information, and International Memorandum of Understandings. Foreign Affairs/Trade: ongoing international issues, patent issues, access and benefit sharing issues, international aid programs. Finance: Budget and budget update. CIDA: international aid programs. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Details Regarding the Identified Subject Matter
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Government institutions added through a communication report: |
Public Safety Canada (PS)
View
|
This is the responsible officer name as provided in the most recent registration for the corporation or organization.
| Name | From | To |
|---|---|---|
| Hoffmann-La Roche Limited | 2024-04-05 | current |
| Hoffmann-La Roche Limited | 2008-08-13 | 2024-04-05 |
| Responsible Officer Name | From (YYYY-MM-DD) | To (YYYY-MM-DD) |
|---|---|---|
| BRIGITTE NOLET | 2022-08-01 | Current |
| RONNIE MILLER | 2001-01-18 | 2022-08-01 |
Registrants are required to submit a monthly communication report for each oral and arranged communication with a designated public office holder. The name of the most senior paid officer (i.e. the registrant) will appear on all in-house monthly communication reports, whether or not he/she participated in the communication.
Note: Monthly Communication Reports are due on the 15th day of each month for communications that took place in the previous month.
Results below are sorted by posted date, beginning with the most recent.
Registrants are required to submit a monthly communication report for each oral and arranged communication with a designated public office holder. The name of the most senior paid officer (i.e. the registrant) will appear on all in-house monthly communication reports, whether or not he/she participated in the communication.
Note: Monthly Communication Reports are due on the 15th day of each month for communications that took place in the previous month.
Results below are sorted by posted date, beginning with the most recent.